S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NASDAQ:SSKN

STRATA Skin Sciences (SSKN) Stock Price, News & Analysis

$0.44
-0.02 (-4.30%)
(As of 03/27/2024 ET)
Today's Range
$0.44
$0.49
50-Day Range
$0.44
$0.56
52-Week Range
$0.26
$1.15
Volume
83,960 shs
Average Volume
14,744 shs
Market Capitalization
$15.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.80

STRATA Skin Sciences MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
754.1% Upside
$3.80 Price Target
Short Interest
Healthy
1.19% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.47mentions of STRATA Skin Sciences in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.23) to ($0.07) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.74 out of 5 stars

Medical Sector

799th out of 939 stocks

Surgical & Medical Instruments Industry

83rd out of 96 stocks

SSKN stock logo

About STRATA Skin Sciences Stock (NASDAQ:SSKN)

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also provides TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

SSKN Stock Price History

SSKN Stock News Headlines

Recap: Strata Skin Sciences Q4 Earnings
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
SSKN STRATA Skin Sciences, Inc.
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Strata Skin Sciences Inc SSKN
STRATA Skin Sciences Reports Third Quarter 2023 Revenue
STRATA Skin Sciences Q3 2023 Earnings Preview
See More Headlines
Receive SSKN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/31/2023
Today
3/27/2024
Next Earnings (Confirmed)
3/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:SSKN
Employees
114
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.80
High Stock Price Target
$3.80
Low Stock Price Target
$3.80
Potential Upside/Downside
+754.1%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-5,550,000.00
Pretax Margin
-20.22%

Debt

Sales & Book Value

Annual Sales
$36.16 million
Cash Flow
$0.01 per share
Book Value
$0.63 per share

Miscellaneous

Free Float
20,879,000
Market Cap
$15.59 million
Optionable
Not Optionable
Beta
1.60

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Christopher Lesovitz (Age 42)
    Chief Financial Officer
    Comp: $313.75k
  • Mr. Shmuel Gov (Age 64)
    Chief Operating Officer
    Comp: $470.52k
  • Dr. Dolev Rafaeli Ph.D. (Age 60)
    President, CEO & Vice-Chairman
    Comp: $282.72k
  • Mr. Jay Sturm (Age 68)
    General Counsel & Corporate Secretary
  • Mr. Michael E. Goodman
    Head of International Sales
  • Mr. Michael R. Stewart (Age 67)
    Independent Consultant
    Comp: $732.9k

SSKN Stock Analysis - Frequently Asked Questions

What is STRATA Skin Sciences' stock price target for 2024?

0 Wall Street research analysts have issued twelve-month price objectives for STRATA Skin Sciences' stock. Their SSKN share price targets range from $3.80 to $3.80. On average, they expect the company's share price to reach $3.80 in the next twelve months. This suggests a possible upside of 754.1% from the stock's current price.
View analysts price targets for SSKN
or view top-rated stocks among Wall Street analysts.

How have SSKN shares performed in 2024?

STRATA Skin Sciences' stock was trading at $0.5501 at the beginning of 2024. Since then, SSKN stock has decreased by 19.1% and is now trading at $0.4449.
View the best growth stocks for 2024 here
.

How were STRATA Skin Sciences' earnings last quarter?

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) posted its earnings results on Friday, March, 31st. The medical device company reported ($0.05) earnings per share for the quarter. The medical device company earned $10.60 million during the quarter. STRATA Skin Sciences had a negative net margin of 20.40% and a negative trailing twelve-month return on equity of 38.76%. During the same quarter last year, the business earned ($0.02) EPS.

When did STRATA Skin Sciences' stock split?

Shares of STRATA Skin Sciences reverse split before market open on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 9th 2014. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of STRATA Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include Trevena (TRVN), Amarin (AMRN), Biocept (BIOC), Kopin (KOPN), OPKO Health (OPK), Plug Power (PLUG), AbbVie (ABBV), SCYNEXIS (SCYX), Tonix Pharmaceuticals (TNXP) and Agile Therapeutics (AGRX).

Who are STRATA Skin Sciences' major shareholders?

STRATA Skin Sciences' stock is owned by a number of retail and institutional investors. Top institutional investors include Nantahala Capital Management LLC (8.93%), Cannell Capital LLC (0.79%) and Chicago Partners Investment Group LLC (0.18%). Insiders that own company stock include Christopher Lesovitz, Robert Joseph Moccia, Samuel Rubinstein, Shmuel Gov and William D Humphries.
View institutional ownership trends
.

How do I buy shares of STRATA Skin Sciences?

Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:SSKN) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners